Shiddiky Laboratory
Back to News
February 08, 2022
Now is the right time to do a PhD - Congratulations Mohamed!
With over 15 years working experiences as researcher and start-up mentor, Mohamed decided to do a PhD on nanobiotechnology and molecular diagnostics. We congratulate and welcome Mohamed to the Shiddiky Laboratory at ESC and QMNC.
By Shiddiky Laboratory
Now is the right time to do a PhD - Congratulations Mohamed!

Mohamed Sallam is a new PhD student at the Shiddiky Laboratory within the School of Environment and Science (ESC) at Griffith University, affiliated with the Queensland Micro and Nanotechnology Centre (QMNC) (Griffith University). Welcome, Mohamed!

Congratulations are in order, as he won a highly competitive Griffith University Postgraduate Research Scholarship/Griffith University International Postgraduate Research Scholarship for his PhD study at the Shiddiky Laboratory.

Mohamed Sallam was born and raised in Cairo (Egypt) and graduated from the Faculty of Science, Ain Shams University (Egypt) in 1999 with a B.Sc. in Biochemistry and Chemistry (Honours). From 1999 to 2002, Mohamed was a Research Assistant in immunology and genetic engineering at Research & Training Center on Vector of Disease RTC, Ain Shams University, Cairo (Egypt). This was a collaboration position with Washington State University and the Barnes Jewish Hospital St Louis. During the same period, he was the genetic engineering technical representative and sales manager for FISH technique (molecular labelled probes, Vysis Inc, USA and fluorescent microscopes from Olympus, Germany) for early detection of proto-oncogene of various types of cancer, in Egypt, England, and Germany.

From 2005 to 2010, Mohamed was Technical Development Manager at Egyptian Mud Engineering & Chemicals Company EMEC, responsible for market research and market development for the most recent technologies in the field of fluids engineering. Together with multiple teams (programmers, mathematicians, numerical analysts, data scientists, graphic designers and database administrators), they developed a state-of-the-art downhole drilling simulator. Afterwards, M. Sallam provided technical support services for field operations engineers 24h/7days a week to maintain rapid response to operational problems. In addition, he prepared training materials for staff members, brochures, technical notes and operation manuals. Then he trained and coached the company’s staff members (3600 Engineers, within 13 countries in the MENA, GCC and East Europe regions) including managers, district managers, area supervisors, and fluids engineers. From 2002 to 2005, he was the drilling fluids operations specialist for Syria, Iraq and Libya at EMEC, performing and troubleshooting all technical issues in field operations.

Previously, from 2010 to 2013, Mohamed was a teacher and research assistant at American University in Cairo (Egypt) in collaboration with Vrije Universiteit Brussel VUB (Belgium), responsible for managing and executing a collaboration project for developing new diagnostic and therapeutic green-chemistry techniques for various diseases including breast cancer and a range of other parasitic diseases (e.g., Malaria, Trypanosomiasis, Bilharziasis and Filariasis). The project was mainly about developing mAbs and single-domain antibodies – Nanobodies - VHH against target specific antigens and bioconjugation with metallic nanoparticles and grapheme coated magnetic nanoparticles for theranostic applications.

From 2013 to 2018, Mohamed was a scientific researcher at Vlaams Interuniversitair Instituut voor Biotechnologie VIB in collaboration with Janssen Pharmaceutica, Johnson and Johnson, responsible for structural characterization of the intrinsically disordered region of the human androgen receptor and its splice variants for drug development against castration-resistant prostate cancer. The research collaboration utilized a wide range of state-of-the-art biophysical and biochemical techniques for small molecules high-throughput screening, protein-protein interaction, and complex formation inhibitors. In 2013, Mohamed was a scientific researcher at German Cancer Research Center – DKFZ and Nationales Centrum für Tumorerkrankungen - NCT Heidelberg, responsible for developing novel bi-specific CAR designs for breast cancer T cell immunotherapy. The research work was in collaboration with Bayer Pharma, Germany, where genetically modified T cells could be alternatively generated using novel transposons systems to stably introduce CARs in T lymphocytes.

From 2018 till January 2022, Mohamed was a start-up mentor at imec.istart company, a subsidiary technology business-interface entity of IMEC, the world-leading R&D and innovation hub in nano-electronics and digital technologies. The main role of ‘imec.istart mentorship’ is to unite a group of leading industry and business professionals eager to share their experienced insights and advice with one or more mentees.

We congratulate and welcome Mohamed to our Laboratory and wish him all the very best.

We look forward to witnessing his future global achievements.

Shiddiky Laboratory
Research
Publications
News
Future Member
Contact
Copyright © 2022 Shiddiky Laboratory. All Rights Reserved. Designed & Developed by@abdnahid_